How to Help Your Patients Save Money on Apixaban: A Provider's Guide to Savings Programs

Cost Is the Biggest Adherence Barrier for Anticoagulant Therapy

Apixaban (brand name Eliquis) is one of the most effective direct oral anticoagulants available — but for years, its cost has been a significant barrier to adherence. Even with the introduction of generic Apixaban in late 2024, many patients still face confusion about pricing, coverage gaps, and which savings options apply to their situation.

As a prescriber, you're often the first person patients turn to when they can't afford their medication. This guide provides a practical framework for helping patients navigate Apixaban costs, including manufacturer programs, discount tools, generic substitution strategies, and how to integrate cost conversations into your clinical workflow.

What Patients Are Actually Paying

Understanding the price landscape helps you guide patients more effectively:

• Brand-name Eliquis (no insurance): $500–$600/month for 60 tablets of 5 mg
• Generic Apixaban (no insurance): $30–$80/month, depending on pharmacy and manufacturer
• With commercial insurance: Eliquis is typically Tier 3 (preferred brand), with copays ranging from $30–$90/month depending on the plan. Generic Apixaban is often Tier 1 or 2 with copays under $20.
• Medicare Part D: Coverage varies by plan. Patients in the donut hole may face significant out-of-pocket costs for brand Eliquis. Generic Apixaban has dramatically improved affordability for Medicare patients.
• Uninsured patients: Cash-pay generic Apixaban at $30–$80/month is now accessible, but some patients still present with sticker shock from brand pricing or are unaware generics exist.

The key takeaway: most patients can now afford Apixaban, but many don't know about their options unless someone tells them.

Manufacturer Savings Programs

Eliquis Savings Card (Bristol-Myers Squibb / Pfizer)

The brand manufacturer offers a co-pay savings card for commercially insured patients:

• Eligible patients may pay as little as $10/month
• Covers up to $6,400/year in savings
• Available at eliquis.com
• Not valid for government-insured patients (Medicare, Medicaid, Tricare, VA)

This card is most useful for commercially insured patients who are still on brand Eliquis and face high copays. For patients who have been switched to generic, the card typically doesn't apply.

Bristol-Myers Squibb Patient Assistance Foundation

For uninsured or underinsured patients who cannot afford their medication:

• Provides free Eliquis to qualifying patients
• Income-based eligibility (typically ≤300% of federal poverty level)
• Requires application and documentation
• Apply through BMS Access Support

Pfizer RxPathways

Pfizer's patient assistance portal connects eligible patients to:

• Free or reduced-cost medication programs
• Insurance support services
• Co-pay assistance for eligible commercially insured patients

Your office staff can help patients initiate applications. Many of these programs accept fax-based enrollment, and approval timelines are typically 2-4 weeks.

Coupon and Discount Cards

For patients paying cash or facing high copays on generic Apixaban, discount card platforms can provide meaningful savings:

• GoodRx — Shows real-time prices at nearby pharmacies with free coupons. Generic Apixaban prices often drop to $30–$50/month with a GoodRx coupon.
• SingleCare — Similar pharmacy comparison and coupon tool.
• RxSaver — Compares prices and offers transferable coupons.
• Optum Perks — Discount card affiliated with UnitedHealth Group.
• BuzzRx, CareCard, America's Pharmacy — Additional options your patients can check.

These tools are free, require no enrollment, and work at most major pharmacy chains. Consider printing a GoodRx or SingleCare card for Apixaban and keeping copies in your exam rooms or at checkout.

Important Note on Coupon Cards vs. Insurance

Coupon card prices and insurance copays are separate. Some patients will find that their insurance copay for generic Apixaban is actually higher than the cash price with a discount card. Encourage patients to ask their pharmacist to compare both options at the counter.

Generic Alternatives and Therapeutic Substitution

Generic Apixaban

Multiple generic manufacturers began producing Apixaban in late 2024 following patent litigation settlements with Bristol-Myers Squibb and Pfizer. Key points for prescribers:

• Generic Apixaban is bioequivalent to brand Eliquis per FDA standards
• Available in both 2.5 mg and 5 mg tablets
• Cash price is approximately $30–$80/month vs. $500–$600 for brand
• Most pharmacies now stock generic by default unless brand is specifically requested

If you've been writing "Eliquis" on prescriptions, ensure your prescribing reflects willingness to allow generic substitution (i.e., do not check "dispense as written" unless clinically necessary). This single step can save patients hundreds of dollars per month.

Therapeutic Alternatives

If cost remains prohibitive even with generic Apixaban, consider therapeutic alternatives based on the clinical scenario:

• Warfarin (Coumadin) — $4–$10/month generic. Requires INR monitoring and dietary management, but remains effective for AFib stroke prevention and DVT/PE treatment. Best for patients who can reliably attend monitoring appointments.
• Rivaroxaban (Xarelto) — Another Factor Xa inhibitor. Generic expected in coming years but still brand-only for most formulations. Once-daily dosing may improve adherence for some patients.
• Dabigatran (Pradaxa) — Direct thrombin inhibitor. Generic availability has been limited. Twice-daily dosing with higher GI side effect profile.
• Edoxaban (Savaysa) — Once-daily Factor Xa inhibitor. Less commonly prescribed but may be an option in specific clinical scenarios.

For a detailed comparison, see our clinical guide: Alternatives to Apixaban.

Building Cost Conversations into Your Clinical Workflow

Many providers avoid cost conversations due to time constraints or discomfort. Here are practical strategies to integrate them efficiently:

1. Ask About Cost at Every Anticoagulant Visit

A simple question — "Are you having any trouble affording your Apixaban?" — can uncover adherence issues before they lead to missed doses and adverse events. Patients often won't volunteer this information unless asked directly.

2. Prescribe Generic by Default

Unless there's a specific clinical reason for brand-name Eliquis, prescribe Apixaban generically and ensure "substitution permitted" is selected in your EHR. Review existing patients on brand Eliquis who might benefit from switching to generic.

3. Keep Savings Resources Accessible

Have your staff maintain a current list of:

• Manufacturer savings card enrollment links
• Patient assistance program applications
• Printed GoodRx/SingleCare coupons for common medications
• Links to Medfinder for Providers — a tool that helps your team find which pharmacies have medications in stock

4. Coordinate with Pharmacy

Establish relationships with local pharmacies that consistently stock generic Apixaban at competitive prices. Some independent pharmacies offer better cash pricing than chain pharmacies. Knowing which pharmacies to recommend saves patients time and money.

5. Document Cost Discussions

Document cost conversations and interventions in the patient's chart. This helps other providers on the care team understand the patient's financial situation and avoids redundant conversations. It also creates a record that supports prior authorization appeals if needed.

6. Use Social Workers and Care Coordinators

If your practice has social workers, care coordinators, or patient navigators, involve them in connecting patients with assistance programs. They can handle the enrollment paperwork and follow-up that you may not have time for during a clinical visit.

When Patients Can't Find Apixaban in Stock

Cost isn't the only barrier — availability matters too. Some patients find that their pharmacy is out of stock, especially when switching between generic manufacturers. A few resources to share with your patients and staff:

• Medfinder for Providers — Helps your practice identify pharmacies with current Apixaban stock, so you can direct patients to the right place at the point of prescribing.
• Encourage patients to read: How to Check If a Pharmacy Has Apixaban in Stock

For a comprehensive overview of the current supply situation, see our provider-focused article: Apixaban Shortage: What Providers Need to Know.

Final Thoughts

The arrival of generic Apixaban has been transformative for affordability, but patients still need guidance to access the best price. By defaulting to generic prescribing, keeping savings resources handy, and normalizing cost conversations in clinical encounters, you can significantly improve adherence and outcomes for your anticoagulant patients.

The tools exist — manufacturer programs, discount cards, patient assistance, and generic alternatives. The challenge is connecting patients to the right resource at the right time. That's where your role as a provider is irreplaceable.

Visit Medfinder for Providers to see how we can help your practice support patients in finding and affording their medications.